Source: Clinical Oral Investigations. Unidade: FO
Subjects: OSTEONECROSE, MANDÍBULA
ABNT
GARET, Bassel Traboulsi et al. Is serum C‑terminal telopeptide cross‑link of type 1 collagen a reliable parameter for predicting the risk of medication‑related osteonecrosis of the jaws? A systematic review and meta‑analysis of diagnostic test accuracy. Clinical Oral Investigations, v. 26, n. Ja 2022, 2022Tradução . . Acesso em: 05 jun. 2023.APA
Garet, B. T., García, A. J., Font, O. C., Alves, F. A., Figueiredo, R., & Castellón, E. V. (2022). Is serum C‑terminal telopeptide cross‑link of type 1 collagen a reliable parameter for predicting the risk of medication‑related osteonecrosis of the jaws? A systematic review and meta‑analysis of diagnostic test accuracy. Clinical Oral Investigations, 26( Ja 2022). doi:10.1007/s00784-022-04383-3NLM
Garet BT, García AJ, Font OC, Alves FA, Figueiredo R, Castellón EV. Is serum C‑terminal telopeptide cross‑link of type 1 collagen a reliable parameter for predicting the risk of medication‑related osteonecrosis of the jaws? A systematic review and meta‑analysis of diagnostic test accuracy. Clinical Oral Investigations. 2022 ; 26( Ja 2022):[citado 2023 jun. 05 ]Vancouver
Garet BT, García AJ, Font OC, Alves FA, Figueiredo R, Castellón EV. Is serum C‑terminal telopeptide cross‑link of type 1 collagen a reliable parameter for predicting the risk of medication‑related osteonecrosis of the jaws? A systematic review and meta‑analysis of diagnostic test accuracy. Clinical Oral Investigations. 2022 ; 26( Ja 2022):[citado 2023 jun. 05 ]